COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Clinical Trial to Evaluate the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
Trial ID or NCT#
Status
RECRUITING
Purpose
The HeartAssist 5® VAD System is intended for use as a bridge-to-heart transplantation and will be compared to the HeartMate II and HVAD devices.
Patients that meet the study criteria will be randomized 1:1 to either the HeartAssist 5® VAD System (treatment group) or control group (HeartMate II and HVAD). The physician will have the option to choose which control device to implant.
The primary objective of the study is to show non-inferiority of the HeartAssist 5® (treatment group) to the control group.
Investigator(s)
Contact us to find out if this trial is right for you.
CONTACT
Kokil Bakshi
View on ClinicalTrials.gov